From studies in anogenital and head and neck cancers it is well known that HR-HPV oncogenes, once they are expressed, interact with cellular cell cycle regulators and contribute to uncontrolled cell proliferation, most importantly by degradation of pRB and p53 (Scheffner et al, 1990). The gene discussed is TP53; the disease is head and neck cancer.